Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Mouse cytomegalovirus m153 protein stabilizes expression of the inhibitory NKR-P1B ligand, Clr-b.

Aguilar OA, Sampaio IS, Rahim MMA, Samaniego JD, Tilahun ME, Krishnamoorthy M, Popović B, Babić M, Krmpotić A, Treanor B, Margulies DH, Allan DSJ, Makrigiannis AP, Jonjić S, Carlyle JR.

J Virol. 2019 Oct 9. pii: JVI.01220-19. doi: 10.1128/JVI.01220-19. [Epub ahead of print]

PMID:
31597762
2.

Systematic review of controlled clinical studies using umbilical cord blood for regenerative therapy: Identifying barriers to assessing efficacy.

Aziz J, Liao G, Adams Z, Rizk M, Shorr R, Allan DS.

Cytotherapy. 2019 Oct 3. pii: S1465-3249(19)30843-6. doi: 10.1016/j.jcyt.2019.08.004. [Epub ahead of print] Review.

PMID:
31587876
3.

c-Maf regulates the plasticity of group 3 innate lymphoid cells by restraining the type 1 program.

Parker ME, Barrera A, Wheaton JD, Zuberbuehler MK, Allan DSJ, Carlyle JR, Reddy TE, Ciofani M.

J Exp Med. 2019 Sep 30. pii: jem.20191030. doi: 10.1084/jem.20191030. [Epub ahead of print]

PMID:
31570496
4.

Obstetrical and neonatal factors associated with optimal public banking of umbilical cord blood in the context of delayed cord clamping.

Munro A, Corsi DJ, Martin L, Halpenny M, Dibdin N, Elmoazzen HE, Walker M, Allan DS.

Clin Invest Med. 2019 Sep 29;42(3):E56-E63. doi: 10.25011/cim.v42i3.33093.

PMID:
31563161
5.

Evaluating dose-limiting toxicities of MDM2 inhibitors in patients with solid organ and hematologic malignancies: A systematic review of the literature.

Pi L, Rooprai J, Allan DS, Atkins H, Bredeson C, Fulcher AJ, Ito C, Ramsay T, Shorr, Stanford WL, Sabloff M, Christou G.

Leuk Res. 2019 Sep 5;86:106222. doi: 10.1016/j.leukres.2019.106222. [Epub ahead of print]

PMID:
31522038
6.

Concise Review: Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Regenerative Therapy and Immune Modulation: Progress and Challenges Toward Clinical Application.

Allan DS, Tieu A, Lalu M, Burger D.

Stem Cells Transl Med. 2019 Aug 14. doi: 10.1002/sctm.19-0114. [Epub ahead of print]

7.

Antibiotic-Resistant Acinetobacter baumannii Is Susceptible to the Novel Iron-Sequestering Anti-infective DIBI In Vitro and in Experimental Pneumonia in Mice.

Parquet MDC, Savage KA, Allan DS, Ang MTC, Chen W, Logan SM, Holbein BE.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e00855-19. doi: 10.1128/AAC.00855-19. Print 2019 Sep.

PMID:
31209004
8.

Mitochondrial adaptation in human mesenchymal stem cells following ionizing radiation.

Patten DA, Ouellet M, Allan DS, Germain M, Baird SD, Harper ME, Richardson RB.

FASEB J. 2019 Aug;33(8):9263-9278. doi: 10.1096/fj.201801483RR. Epub 2019 May 21.

9.

The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-Myc.

Dong H, Adams NM, Xu Y, Cao J, Allan DSJ, Carlyle JR, Chen X, Sun JC, Glimcher LH.

Nat Immunol. 2019 Jul;20(7):865-878. doi: 10.1038/s41590-019-0388-z. Epub 2019 May 13.

PMID:
31086333
10.

Erratum for Savage et al., "Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles In Vitro and In Vivo in a Murine Model of Experimental Vaginitis".

Savage KA, Parquet MDC, Allan DS, Davidson RJ, Holbein BE, Lilly EA, Fidel PL Jr.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e02508-18. doi: 10.1128/AAC.02508-18. Print 2019 Feb. No abstract available.

11.

Receptor-Ligand Interaction Mediates Targeting of Endothelial Colony Forming Cell-derived Exosomes to the Kidney after Ischemic Injury.

Viñas JL, Spence M, Gutsol A, Knoll W, Burger D, Zimpelmann J, Allan DS, Burns KD.

Sci Rep. 2018 Nov 5;8(1):16320. doi: 10.1038/s41598-018-34557-7.

12.

Reversing pathological remodelling of the bone marrow microenvironment in acute myeloid leukemia.

Allan DS, De Lisio M.

Stem Cell Investig. 2018 Sep 26;5:29. doi: 10.21037/sci.2018.09.02. eCollection 2018. No abstract available.

13.

Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro.

Parquet MDC, Savage KA, Allan DS, Davidson RJ, Holbein BE.

Front Microbiol. 2018 Aug 14;9:1811. doi: 10.3389/fmicb.2018.01811. eCollection 2018.

14.

DIBI, a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity.

Ang MTC, Gumbau-Brisa R, Allan DS, McDonald R, Ferguson MJ, Holbein BE, Bierenstiel M.

Medchemcomm. 2018 Jun 18;9(7):1206-1212. doi: 10.1039/c8md00192h. eCollection 2018 Jul 1.

15.

The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells.

Bando JK, Gilfillan S, Song C, McDonald KG, Huang SC, Newberry RD, Kobayashi Y, Allan DSJ, Carlyle JR, Cella M, Colonna M.

Immunity. 2018 Jun 19;48(6):1208-1219.e4. doi: 10.1016/j.immuni.2018.04.012. Epub 2018 May 29.

16.
17.

The Inhibitory NKR-P1B:Clr-b Recognition Axis Facilitates Detection of Oncogenic Transformation and Cancer Immunosurveillance.

Tanaka M, Fine JH, Kirkham CL, Aguilar OA, Belcheva A, Martin A, Ketela T, Moffat J, Allan DSJ, Carlyle JR.

Cancer Res. 2018 Jul 1;78(13):3589-3603. doi: 10.1158/0008-5472.CAN-17-1688. Epub 2018 Apr 24.

18.

Author Response: Delayed Cord Clamping and Umbilical Cord Blood Collection.

Armson BA, Allan DS, Casper RF.

J Obstet Gynaecol Can. 2018 Feb;40(2):155. doi: 10.1016/j.jogc.2017.10.003. No abstract available.

PMID:
29447708
19.

Network geometry of evidence from randomised controlled trials addressing donor selection and source of haematopoietic progenitor cells used in allogeneic transplantation: a systematic scoping review.

Monaghan M, Rizk M, Pilon S, Iyengar A, Shorr R, Tay J, Maze D, Bredeson C, Hutton B, Allan DS.

Transfus Med. 2018 Oct;28(5):371-379. doi: 10.1111/tme.12509. Epub 2018 Jan 30.

PMID:
29380924
20.

Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection.

Greco-Stewart V, Kiernan J, Killeen D, Haun S, Mercer D, Young K, Liwski RS, Allan DS.

Transfusion. 2018 Mar;58(3):718-725. doi: 10.1111/trf.14458. Epub 2017 Dec 25.

PMID:
29277913
21.

Bacillus anthracis lethal toxin negatively modulates ILC3 function through perturbation of IL-23-mediated MAPK signaling.

Seshadri S, Allan DSJ, Carlyle JR, Zenewicz LA.

PLoS Pathog. 2017 Oct 23;13(10):e1006690. doi: 10.1371/journal.ppat.1006690. eCollection 2017 Oct.

22.

Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche.

Boyd AL, Reid JC, Salci KR, Aslostovar L, Benoit YD, Shapovalova Z, Nakanishi M, Porras DP, Almakadi M, Campbell CJV, Jackson MF, Ross CA, Foley R, Leber B, Allan DS, Sabloff M, Xenocostas A, Collins TJ, Bhatia M.

Nat Cell Biol. 2017 Nov;19(11):1336-1347. doi: 10.1038/ncb3625. Epub 2017 Oct 16.

PMID:
29035359
23.

Epigenetic Activation of Pro-angiogenic Signaling Pathways in Human Endothelial Progenitors Increases Vasculogenesis.

Fraineau S, Palii CG, McNeill B, Ritso M, Shelley WC, Prasain N, Chu A, Vion E, Rieck K, Nilufar S, Perkins TJ, Rudnicki MA, Allan DS, Yoder MC, Suuronen EJ, Brand M.

Stem Cell Reports. 2017 Nov 14;9(5):1573-1587. doi: 10.1016/j.stemcr.2017.09.009. Epub 2017 Oct 12.

24.

Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.

Barrera-Ramirez J, Lavoie JR, Maganti HB, Stanford WL, Ito C, Sabloff M, Brand M, Rosu-Myles M, Le Y, Allan DS.

Stem Cell Rev Rep. 2017 Dec;13(6):817-825. doi: 10.1007/s12015-017-9762-0.

25.

Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells.

Allan DSJ, Cerdeira AS, Ranjan A, Kirkham CL, Aguilar OA, Tanaka M, Childs RW, Dunbar CE, Strominger JL, Kopcow HD, Carlyle JR.

Sci Rep. 2017 Jun 14;7(1):3501. doi: 10.1038/s41598-017-03256-0.

26.

Cell-Based Therapy Using Umbilical Cord Blood for Novel Indications in Regenerative Therapy and Immune Modulation: An Updated Systematic Scoping Review of the Literature.

Rizk M, Aziz J, Shorr R, Allan DS.

Biol Blood Marrow Transplant. 2017 Oct;23(10):1607-1613. doi: 10.1016/j.bbmt.2017.05.032. Epub 2017 Jun 30. Review.

27.

A Viral Immunoevasin Controls Innate Immunity by Targeting the Prototypical Natural Killer Cell Receptor Family.

Aguilar OA, Berry R, Rahim MMA, Reichel JJ, Popović B, Tanaka M, Fu Z, Balaji GR, Lau TNH, Tu MM, Kirkham CL, Mahmoud AB, Mesci A, Krmpotić A, Allan DSJ, Makrigiannis AP, Jonjić S, Rossjohn J, Carlyle JR.

Cell. 2017 Mar 23;169(1):58-71.e14. doi: 10.1016/j.cell.2017.03.002.

28.

Interferon-Dependent Induction of Clr-b during Mouse Cytomegalovirus Infection Protects Bystander Cells from Natural Killer Cells via NKR-P1B-Mediated Inhibition.

Kirkham CL, Aguilar OA, Yu T, Tanaka M, Mesci A, Chu KL, Fine JH, Mossman KL, Bremner R, Allan DSJ, Carlyle JR.

J Innate Immun. 2017;9(4):343-358. doi: 10.1159/000454926. Epub 2017 Mar 14.

29.

Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells.

Schlums H, Jung M, Han H, Theorell J, Bigley V, Chiang SC, Allan DS, Davidson-Moncada JK, Dickinson RE, Holmes TD, Hsu AP, Townsley D, Winkler T, Wang W, Aukrust P, Nordøy I, Calvo KR, Holland SM, Collin M, Dunbar CE, Bryceson YT.

Blood. 2017 Apr 6;129(14):1927-1939. doi: 10.1182/blood-2016-08-734236. Epub 2017 Feb 16.

30.

Sang de cordon ombilical : Counseling, prélèvement et mise en banque.

Armson BA, Allan DS, Casper RF.

J Obstet Gynaecol Can. 2016 Dec;38(12S):S724-S739. doi: 10.1016/j.jogc.2016.09.073. Epub 2017 Jan 4. No abstract available.

PMID:
28063576
31.

Transfer of microRNA-486-5p from human endothelial colony forming cell-derived exosomes reduces ischemic kidney injury.

Viñas JL, Burger D, Zimpelmann J, Haneef R, Knoll W, Campbell P, Gutsol A, Carter A, Allan DS, Burns KD.

Kidney Int. 2016 Dec;90(6):1238-1250. doi: 10.1016/j.kint.2016.07.015. Epub 2016 Sep 17.

32.

Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials.

Christou G, Iyengar A, Shorr R, Tinmouth A, Saidenberg E, Maze D, Tay J, Bredeson C, Allan DS.

Transfusion. 2016 Oct;56(10):2607-2614. doi: 10.1111/trf.13738. Epub 2016 Jul 27. Review.

PMID:
27465524
33.

Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the Evidence.

Rizk M, Monaghan M, Shorr R, Kekre N, Bredeson CN, Allan DS.

Biol Blood Marrow Transplant. 2016 Aug;22(8):1416-1423. doi: 10.1016/j.bbmt.2016.04.010. Epub 2016 Apr 27. Review.

34.

Eltrombopag after allogeneic haematopoietic cell transplantation in a case of poor graft function and systematic review of the literature.

Dyba J, Tinmouth A, Bredeson C, Matthews J, Allan DS.

Transfus Med. 2016 Jun;26(3):202-7. doi: 10.1111/tme.12300. Epub 2016 Apr 5. Review.

PMID:
27046441
35.

Use of Statins to Augment Progenitor Cell Function in Preclinical and Clinical Studies of Regenerative Therapy: a Systematic Review.

Park A, Barrera-Ramirez J, Ranasinghe I, Pilon S, Sy R, Fergusson D, Allan DS.

Stem Cell Rev Rep. 2016 Jun;12(3):327-39. doi: 10.1007/s12015-016-9647-7.

PMID:
26873165
36.

Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.

Le Y, Fraineau S, Chandran P, Sabloff M, Brand M, Lavoie JR, Gagne R, Rosu-Myles M, Yauk CL, Richardson RB, Allan DS.

Stem Cell Rev Rep. 2016 Apr;12(2):235-44. doi: 10.1007/s12015-015-9639-z.

PMID:
26649729
37.

Umbilical Cord Blood: Counselling, Collection, and Banking.

Armson BA, Allan DS, Casper RF.

J Obstet Gynaecol Can. 2015 Sep;37(9):832-844. doi: 10.1016/S1701-2163(15)30157-2.

PMID:
26605456
38.

Delayed clamping of the umbilical cord after delivery and implications for public cord blood banking.

Allan DS, Scrivens N, Lawless T, Mostert K, Oppenheimer L, Walker M, Petraszko T, Elmoazzen H.

Transfusion. 2016 Mar;56(3):662-5. doi: 10.1111/trf.13424. Epub 2015 Nov 20.

PMID:
26585667
39.

Regenerative Therapy and Immune Modulation Using Umbilical Cord Blood-Derived Cells.

Damien P, Allan DS.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1545-54. doi: 10.1016/j.bbmt.2015.05.022. Epub 2015 Jun 14. Review.

40.

Human endothelial colony-forming cells protect against acute kidney injury: role of exosomes.

Burger D, Viñas JL, Akbari S, Dehak H, Knoll W, Gutsol A, Carter A, Touyz RM, Allan DS, Burns KD.

Am J Pathol. 2015 Aug;185(8):2309-23. doi: 10.1016/j.ajpath.2015.04.010. Epub 2015 Jun 12.

PMID:
26073035
41.

Modulation of Clr Ligand Expression and NKR-P1 Receptor Function during Murine Cytomegalovirus Infection.

Aguilar OA, Mesci A, Ma J, Chen P, Kirkham CL, Hundrieser J, Voigt S, Allan DS, Carlyle JR.

J Innate Immun. 2015;7(6):584-600. doi: 10.1159/000382032. Epub 2015 May 29.

42.

Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors.

Chandran P, Le Y, Li Y, Sabloff M, Mehic J, Rosu-Myles M, Allan DS.

Leuk Res. 2015 Apr;39(4):486-93. doi: 10.1016/j.leukres.2015.01.013. Epub 2015 Feb 2.

PMID:
25703353
43.

Genetic investigation of MHC-independent missing-self recognition by mouse NK cells using an in vivo bone marrow transplantation model.

Chen P, Aguilar OA, Rahim MM, Allan DS, Fine JH, Kirkham CL, Ma J, Tanaka M, Tu MM, Wight A, Kartsogiannis V, Gillespie MT, Makrigiannis AP, Carlyle JR.

J Immunol. 2015 Mar 15;194(6):2909-18. doi: 10.4049/jimmunol.1401523. Epub 2015 Feb 13.

44.

Epigenetic regulation of endothelial-cell-mediated vascular repair.

Fraineau S, Palii CG, Allan DS, Brand M.

FEBS J. 2015 May;282(9):1605-29. doi: 10.1111/febs.13183. Epub 2015 Jan 14. Review.

45.

Current trends in clinical studies of allogeneic hematopoietic stem cell transplantation.

Pilon S, Jedrysiak D, Sheppard D, Bredeson CN, Tay J, Allan DS.

Biol Blood Marrow Transplant. 2015 Feb;21(2):364-70. doi: 10.1016/j.bbmt.2014.09.014. Epub 2014 Oct 19.

46.

An in vitro model of innate lymphoid cell function and differentiation.

Allan DS, Kirkham CL, Aguilar OA, Qu LC, Chen P, Fine JH, Serra P, Awong G, Gommerman JL, Zúñiga-Pflücker JC, Carlyle JR.

Mucosal Immunol. 2015 Mar;8(2):340-51. doi: 10.1038/mi.2014.71. Epub 2014 Aug 20.

PMID:
25138665
47.

Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation.

Christou G, Kekre N, Petrcich W, Tokessy M, Neurath D, Giulivi A, Saidenberg E, McDiarmid S, Atkins H, Bence-Bruckler I, Bredeson C, Huebsch L, Sabloff M, Sheppard D, Tay J, Tinmouth A, Allan DS.

Transfusion. 2015 Feb;55(2):253-8. doi: 10.1111/trf.12817. Epub 2014 Aug 15.

PMID:
25125085
48.

A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles.

Akyurekli C, Le Y, Richardson RB, Fergusson D, Tay J, Allan DS.

Stem Cell Rev Rep. 2015 Feb;11(1):150-60. doi: 10.1007/s12015-014-9545-9. Review.

PMID:
25091427
49.

RhD and haematopoietic transplantation.

Allan DS, Saidenberg E.

Blood Transfus. 2014 Jul;12(3):290. doi: 10.2450/2014.0083-14. Epub 2014 Jun 5. No abstract available.

50.

Trichostatin A enhances vascular repair by injected human endothelial progenitors through increasing the expression of TAL1-dependent genes.

Palii CG, Vulesevic B, Fraineau S, Pranckeviciene E, Griffith AJ, Chu A, Faralli H, Li Y, McNeill B, Sun J, Perkins TJ, Dilworth FJ, Perez-Iratxeta C, Suuronen EJ, Allan DS, Brand M.

Cell Stem Cell. 2014 May 1;14(5):644-57. doi: 10.1016/j.stem.2014.03.003.

Supplemental Content

Loading ...
Support Center